Canan Özsoy
Independent Board Member & Advisor to Board at various Companies, PhD Student @ OZU and Green ENERGY Transformation Enthusiast
YEO•Istanbul, Istanbul, Türkiye
View LinkedIn ProfileExperience34+ Years
LevelLeadership
Executive Overview
Vice Chair of AmCham Turkey, Board Member of BBVA Garanti Bank. Vice Chair of SEV Foundation. Chairwomen of GE Turkey.
Career Timeline
- YEOCurrentFeb 2026–Present· 8 mos
- Board MemberCurrentFeb 2026–Present
- BİOTRENDCurrent2026–Present· 9 mos
- Chairperson of the BoardCurrent2026–Present
- Global Investment HoldingsCurrentJul 2025–Present· 1 yr 3 mos
- Independent Board MemberCurrentJul 2025–Present
- Garanti BBVACurrentApr 2018–Present· 8 yrs 6 mos
- Board MemberCurrentApr 2018–Present
- Nov 2022–Nov 2025· 3 yrs
- Advisor to the BoardNov 2022–Nov 2025
- Mar 2022–Mar 2026· 4 yrs
- Advisor to the BoardMar 2022–Mar 2026
- Aug 2012–Dec 2022· 10 yrs 4 mos
- President & CEO of GE in TurkeyAug 2012–Dec 2022
- Mar 2007–Sep 2012· 5 yrs 6 mos
- General Manager Global MammographyNov 2011–Sep 2012
- Chief Marketing Officer GE Healthcare SystemsMar 2009–Nov 2011
- Vice President, Marketing, InternationalMar 2007–Mar 2009
- 2000–Mar 2004· 4 yrs 2 mos
- International Business Unit DirectorMar 2000–Mar 2004
- Director, Business Unit2000–2004
- 1992–1993· 1 yr
- Manager, Marketing1992–1993
Education
PhD student
Energy Transition
Özyeğin UniversityMaster's degree
Energy Technologies
Sabanci UniversityMBA
Executive MBA
Boğaziçi UniversityDoctor of Dentistry
Dental Science
Istanbul UniversityDoctor of Philosophy - PhD
ENERGY
Özyeğin UniversityExecutive Relationship Map
Reports To
Canan Özsoy
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
Product DevelopmentMarketingSales EffectivenessProduct LaunchMergers & Acquisitions21st Century Leadership skillsStrategy & Innovation ProcessStrategyStrategic PlanningMedical DevicesMarket DevelopmentCross-functional Team Leadershipcommercial excellenceInnovationBusinessMergersPharmaceutical SalesPharmaceutical IndustryBiotechnologyMarket Access